SERUM IMMUNOGLOBULIN LEVELS IN RELATION TO LEVELS OF SPECIFIC ANTIBODIES IN ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANT RECIPIENTS
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 69 (8) , 1582-1586
- https://doi.org/10.1097/00007890-200004270-00011
Abstract
Background. The aim of this study was to investigate the correlation of total levels of immunoglobulins to levels of specific antibodies after allogeneic and autologous bone marrow transplantation.Autologous transplant patients had normal levels of IgA and IgG antibodies already at 6 months after transplantation. In allogeneic transplanted patients without chronic graft versus host disease the immunological recovery was slower. The IgA and IgG levels were at the limit for deficiency at 6 months after transplantation. In allogeneic transplant patients with chronic chronic graft versus host disease the immunological recovery was delayed further. The total IgG levels were low at 12 months after transplantation and the IgG subclass pattern did not normalize until 24 months after transplantation. IgA levels remained low at 24 months after transplantation in all allogeneic transplanted patients with chronic chronic graft versus host disease. Protective levels of specific antibodies against tetanus and pneumococci decreased during the first year after transplantation regardless of the total immunoglobulin levels, regardless of the donors immunity. Pneumococcal antibodies decreased only in allogeneic transplanted patients, although autologous transplant patients retained pretransplant immunity against pneumococci. There was no difference in levels of specific antibodies between patients with and without chronic chronic graft versus host disease at 12 months after transplantation. There was no correlation between total immunoglobulin levels to levels of specific antibodies against tetanus and pneumococci after transplantation in our study. Taken together, normalized immunoglobulinlevels do not predict normalization of levels of specific antibodies against tetanus and pneumococci after transplantation.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy and Safety of Vaccination of Marrow Transplant Recipients with a Live Attenuated Measles, Mumps, and Rubella VaccineThe Journal of Infectious Diseases, 1989
- Clinical and Subclinical Reactivations of Varicella-Zoster Virus in Immunocompromised PatientsThe Journal of Infectious Diseases, 1986
- TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROWThe Lancet, 1986
- DISORDERED SALIVARY IMMUNOGLOBULIN SECRETION AND SODIUM TRANSPORT IN HUMAN CHRONIC GRAFT-VERSUS-HOST DISEASETransplantation, 1983
- Allogeneic Bone‐Marrow TransplantationImmunological Reviews, 1983
- EXPERIENCE WITH A COOPERATIVE BONE MARROW TRANSPLANTATION PROGRAM IN STOCKHOLMTransplantation, 1982
- IMMUNOLOGICAL RECOVERY IN 48 PATIENTS FOLLOWING SYNGENEIC MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCYTransplantation, 1982
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974
- STUDIES OF IMMUNOLOGICAL REACTIVITY FOLLOWING SYNGENEIC OR ALLOGENEIC MARROW GRAFTS IN MANTransplantation, 1973
- IMMUNOCOMPETENCE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION IN MANTransplantation, 1972